165 related articles for article (PubMed ID: 18800877)
41. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization.
Stenderup K; Rosada C; Justesen J; Al-Soubky T; Dagnaes-Hansen F; Kassem M
Biogerontology; 2004; 5(2):107-18. PubMed ID: 15105585
[TBL] [Abstract][Full Text] [Related]
42. Differential osteogenic activity of osteoprogenitor cells on HA and TCP/HA scaffold of tissue engineered bone.
Ng AM; Tan KK; Phang MY; Aziyati O; Tan GH; Isa MR; Aminuddin BS; Naseem M; Fauziah O; Ruszymah BH
J Biomed Mater Res A; 2008 May; 85(2):301-12. PubMed ID: 17688285
[TBL] [Abstract][Full Text] [Related]
43. Characteristic change and loss of in vivo osteogenic abilities of human bone marrow stromal cells during passage.
Agata H; Asahina I; Watanabe N; Ishii Y; Kubo N; Ohshima S; Yamazaki M; Tojo A; Kagami H
Tissue Eng Part A; 2010 Feb; 16(2):663-73. PubMed ID: 19754223
[TBL] [Abstract][Full Text] [Related]
44. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold.
Boo JS; Yamada Y; Okazaki Y; Hibino Y; Okada K; Hata K; Yoshikawa T; Sugiura Y; Ueda M
J Craniofac Surg; 2002 Mar; 13(2):231-9; discussion 240-3. PubMed ID: 12000879
[TBL] [Abstract][Full Text] [Related]
45. Simultaneous cultivation of human endothelial-like differentiated precursor cells and human marrow stromal cells on beta-tricalcium phosphate.
Henrich D; Seebach C; Kaehling C; Scherzed A; Wilhelm K; Tewksbury R; Powerski M; Marzi I
Tissue Eng Part C Methods; 2009 Dec; 15(4):551-60. PubMed ID: 19199563
[TBL] [Abstract][Full Text] [Related]
46. In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically.
Jeon O; Rhie JW; Kwon IK; Kim JH; Kim BS; Lee SH
Tissue Eng Part A; 2008 Aug; 14(8):1285-94. PubMed ID: 18593269
[TBL] [Abstract][Full Text] [Related]
47. Effect of bone graft substitute on marrow stromal cell proliferation and differentiation.
Siggers K; Frei H; Fernlund G; Rossi F
J Biomed Mater Res A; 2010 Sep; 94(3):877-85. PubMed ID: 20336765
[TBL] [Abstract][Full Text] [Related]
48. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats.
Kruyt MC; de Bruijn JD; Wilson CE; Oner FC; van Blitterswijk CA; Verbout AJ; Dhert WJ
Tissue Eng; 2003 Apr; 9(2):327-36. PubMed ID: 12740095
[TBL] [Abstract][Full Text] [Related]
49. Endothelial cell modulation of bone marrow stromal cell osteogenic potential.
Kaigler D; Krebsbach PH; West ER; Horger K; Huang YC; Mooney DJ
FASEB J; 2005 Apr; 19(6):665-7. PubMed ID: 15677693
[TBL] [Abstract][Full Text] [Related]
50. An ectopic study of tissue-engineered bone with Nell-1 gene modified rat bone marrow stromal cells in nude mice.
Hu JZ; Zhang ZY; Zhao J; Zhang XL; Liu GT; Jiang XQ
Chin Med J (Engl); 2009 Apr; 122(8):972-9. PubMed ID: 19493425
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a novel biphasic calcium phosphate in standardized bone defects: a histologic and histomorphometric study in the mandibles of minipigs.
Jensen SS; Yeo A; Dard M; Hunziker E; Schenk R; Buser D
Clin Oral Implants Res; 2007 Dec; 18(6):752-60. PubMed ID: 17888014
[TBL] [Abstract][Full Text] [Related]
52. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: Scaffold design and its performance when seeded with goat bone marrow stromal cells.
Oliveira JM; Rodrigues MT; Silva SS; Malafaya PB; Gomes ME; Viegas CA; Dias IR; Azevedo JT; Mano JF; Reis RL
Biomaterials; 2006 Dec; 27(36):6123-37. PubMed ID: 16945410
[TBL] [Abstract][Full Text] [Related]
53. Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway.
Chen Z; Wu C; Gu W; Klein T; Crawford R; Xiao Y
Biomaterials; 2014 Feb; 35(5):1507-18. PubMed ID: 24268199
[TBL] [Abstract][Full Text] [Related]
54. Tissue-engineered bone formation using human bone marrow stromal cells and novel beta-tricalcium phosphate.
Liu G; Zhao L; Cui L; Liu W; Cao Y
Biomed Mater; 2007 Jun; 2(2):78-86. PubMed ID: 18458439
[TBL] [Abstract][Full Text] [Related]
55. Improved bone anchorage of hydroxypatite coated implants compared with tricalcium-phosphate coated implants in trabecular bone in dogs.
Lind M; Overgaard S; Bünger C; Søballe K
Biomaterials; 1999 May; 20(9):803-8. PubMed ID: 10226706
[TBL] [Abstract][Full Text] [Related]
56. Maxillary sinus floor elevation using a tissue-engineered bone complex with beta-TCP and BMP-2 gene-modified bMSCs in rabbits.
Jiang XQ; Sun XJ; Lai HC; Zhao J; Wang SY; Zhang ZY
Clin Oral Implants Res; 2009 Dec; 20(12):1333-40. PubMed ID: 19709061
[TBL] [Abstract][Full Text] [Related]
57. Autogenous bone marrow stromal cell sheets-loaded mPCL/TCP scaffolds induced osteogenesis in a porcine model of spinal interbody fusion.
Abbah SA; Lam CX; Ramruttun KA; Goh JC; Wong HK
Tissue Eng Part A; 2011 Mar; 17(5-6):809-17. PubMed ID: 20973747
[TBL] [Abstract][Full Text] [Related]
58. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.
E LL; Xu LL; Wu X; Wang DS; Lv Y; Wang JZ; Liu HC
Tissue Eng Part A; 2010 Sep; 16(9):2927-40. PubMed ID: 20486786
[TBL] [Abstract][Full Text] [Related]
59. Comparison of human bone marrow stromal cells seeded on calcium-deficient hydroxyapatite, beta-tricalcium phosphate and demineralized bone matrix.
Kasten P; Luginbühl R; van Griensven M; Barkhausen T; Krettek C; Bohner M; Bosch U
Biomaterials; 2003 Jul; 24(15):2593-603. PubMed ID: 12726713
[TBL] [Abstract][Full Text] [Related]
60. Mussel-inspired bioceramics with self-assembled Ca-P/polydopamine composite nanolayer: preparation, formation mechanism, improved cellular bioactivity and osteogenic differentiation of bone marrow stromal cells.
Wu C; Han P; Liu X; Xu M; Tian T; Chang J; Xiao Y
Acta Biomater; 2014 Jan; 10(1):428-38. PubMed ID: 24157695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
